SUBSCRIBE
SUBSCRIBE
News   Business

Emergent BioSolutions Signs Contract for up to $186.6 Million

September 20, 2010 | 
1 min read
ROCKVILLE, Md. (AP) -- Emergent BioSolutions Inc. said Friday it signed a contract worth up to $186.6 million with the Department of Health and Human Services to develop an anthrax vaccine.
Alliances
Emergent BioSolutions
MORE ON THIS TOPIC
Dashed line from pills isolated on white
Pipeline
Pfizer culls early PD-L1 asset after series of clinical wins, deals in cancer
April 24, 2026
 · 
2 min read
 · 
Tristan Manalac
IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch
IPO tracker
Avalyn seeks public debut to support new lung drug formulations
April 24, 2026
 · 
11 min read
 · 
Editorial Team
Illustration of two arrows merging into one
Deals
Amneal inks $1.1B Kashiv buyout to pursue biosimilar market leadership
April 23, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Business people run on the arrows. Business concept of competition or target aiming. Flat vector illustration.
Leadership
BBOT shakes up leadership as RAS competitors get more visibility
April 23, 2026
 · 
2 min read
 · 
Annalee Armstrong